HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

RB1 deletion in gonadoblastoma in an XY female.

Abstract
Cytogenetic studies of normal and tumor cells in a patient with gonadal dysgenesis and bilateral gonadoblastoma were performed. The karyotype was 46,XY in peripheral blood lymphocytes and skin fibroblasts. The conserved region of the SRY gene was detected by polymerase chain reaction amplification. Sequencing of this region did not reveal any alterations. A 46,XY chromosome constitution was observed in the right gonadoblastoma, but a partial deletion of chromosome 13 was present in the left tumor. This deletion included band 13q14, where the retinoblastoma gene is mapped. The study of the polymorphism of the variable number of tandem repeats region in intron 17 of the RB1 locus disclosed loss of heterozygosity in both the left tumor, which showed the deletion of chromosome 13, and in the right tumor, where no chromosome alterations of chromosome 13 were detected. In situ hybridization covering 130 kb of RB1 showed that a partial deletion of one of the RB1 alleles had occurred in the right tumor. Since the deletions affected different alleles in each tumor, independent events must have been involved in the development of the tumors. These findings point toward a significant role of RB1 in the development of gonadoblastoma.
AuthorsS Antonini, A S Barbosa, C Rosenberg, A C Barbosa, A C Moreira-Filho, A M Vianna-Morgante
JournalHuman genetics (Hum Genet) Vol. 101 Issue 2 Pg. 181-5 (Dec 1997) ISSN: 0340-6717 [Print] Germany
PMID9402965 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • Adolescent
  • Chromosome Banding
  • Chromosomes, Human, Pair 13
  • Exons
  • Female
  • Gene Deletion
  • Genes, Retinoblastoma
  • Gonadal Dysgenesis, 46,XY (complications, genetics)
  • Gonadoblastoma (complications, genetics)
  • Humans
  • In Situ Hybridization, Fluorescence
  • Polymerase Chain Reaction
  • Sequence Analysis, DNA

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: